Prevention of cisplatin-induced emesis by a neurokinin-1-receptor antagonist.
Roila
F
F
Ballatori
E
E
Del Favero
A
A
D000080:Acetals / Q000627:therapeutic use*; D000932:Antiemetics / Q000627:therapeutic use*; D000077608:Aprepitant; D002945:Cisplatin / Q000009:adverse effects*; D003907:Dexamethasone / Q000627:therapeutic use; D006801:Humans; D008787:Metoclopramide / Q000627:therapeutic use; D009025:Morpholines / Q000627:therapeutic use*; D064729:Neurokinin-1 Receptor Antagonists; D012107:Research Design; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control*
D000080:Acetals; D000932:Antiemetics; D009025:Morpholines; D064729:Neurokinin-1 Receptor Antagonists; D000077608:Aprepitant; D003907:Dexamethasone; D008787:Metoclopramide; D002945:Cisplatin